SIGA Technologies, Inc.

( )
SIGA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. 1.71%30.2614.1%$178.05m
AMRNAmarin Corp. Plc -0.75%19.911.7%$154.89m
AXSMAxsome Therapeutics, Inc. -2.31%90.341.9%$103.93m
SAVACassava Sciences, Inc. -4.40%8.250.0%$98.43m
BHCBausch Health Cos., Inc. 1.71%30.260.0%$78.04m
GWPHGW Pharmaceuticals Plc -0.13%118.976.2%$71.56m
JAZZJazz Pharmaceuticals Plc -0.36%151.052.3%$65.54m
SAGESAGE Therapeutics, Inc. 3.12%76.408.6%$63.37m
ICPTIntercept Pharmaceuticals, Inc. -3.76%106.1116.9%$60.45m
PRGOPerrigo Co. Plc -0.82%59.026.8%$59.97m
HZNPHorizon Therapeutics Plc 0.29%38.406.6%$53.65m
ICLRICON plc 0.38%175.784.2%$41.34m
ENDPEndo International Plc -2.27%6.048.8%$39.89m
PTLAPortola Pharmaceuticals, Inc. -2.84%14.376.7%$36.81m
CTLTCatalent, Inc. -1.03%60.842.4%$35.61m

Company Profile

SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded on December 28, 1995 and is headquartered in New York, NY.